Yamamoto S - Search Results

1

Author Correction: The real-world selection of first-line systemic therapy regimen for metastatic gastroenteropancreatic neuroendocrine neoplasm in Japan.

Yamamoto S, Sakakibara N, Hirano H, Morizane C, Honma Y, Hijioka S, Okusaka T, Higashi T, Kawai A. Yamamoto S, et al. Sci Rep. 2022 Dec 19;12(1):21917. doi: 10.1038/s41598-022-26509-z. Sci Rep. 2022. PMID: 36536045 Free PMC article. No abstract available.

2

Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab.

Masuda K, Shoji H, Nagashima K, Yamamoto S, Ishikawa M, Imazeki H, Aoki M, Miyamoto T, Hirano H, Honma Y, Iwasa S, Okita N, Takashima A, Kato K, Boku N. Masuda K, et al. Among authors: yamamoto s. BMC Cancer. 2019 Oct 21;19(1):974. doi: 10.1186/s12885-019-6150-y. BMC Cancer. 2019. PMID: 31638948 Free PMC article.

3

Short-term outcomes of induction chemotherapy with docetaxel, cisplatin, and fluorouracil (TPF) in locally advanced nasopharyngeal carcinoma.

Takamizawa S, Honma Y, Murakami N, Mori T, Oka H, Yamamoto S, Kashihara T, Ito K, Kubo Y, Ikeda A, Matsumoto F, Omura G, Kobayashi K, Itami J, Kato K, Yoshimoto S. Takamizawa S, et al. Among authors: yamamoto s. Invest New Drugs. 2021 Apr;39(2):564-570. doi: 10.1007/s10637-020-00999-y. Epub 2020 Sep 17. Invest New Drugs. 2021. PMID: 32940872

4

Panitumumab-Associated Drug-Induced Immune Thrombocytopenia in a Patient with Colorectal Cancer.

Takamizawa S, Shoji H, Hirano H, Izutsu K, Yamamoto S, Iwasa S, Honma Y, Okita N, Takashima A, Kato K, Boku N. Takamizawa S, et al. Among authors: yamamoto s. Case Rep Oncol. 2021 Feb 25;14(1):85-89. doi: 10.1159/000512821. eCollection 2021 Jan-Apr. Case Rep Oncol. 2021. PMID: 33776687 Free PMC article.

5

Novel pathological staging for patients with locally advanced esophageal squamous cell carcinoma undergoing neoadjuvant chemotherapy followed by surgery.

Oguma J, Ishiyama K, Kurita D, Kanematsu K, Fujii Y, Kubo K, Yamamoto S, Honma Y, Kato K, Daiko H. Oguma J, et al. Among authors: yamamoto s. Esophagus. 2022 Apr;19(2):214-223. doi: 10.1007/s10388-021-00891-5. Epub 2021 Nov 10. Esophagus. 2022. PMID: 34757482

6

Safety and short-term efficacy of preoperative FOLFOX therapy in patients with resectable esophageal squamous cell carcinoma who are ineligible for cisplatin.

Kadono T, Yamamoto S, Hirose T, Ikeda G, Ohara A, Itoyama M, Yokoyama K, Honma Y, Hashimoto T, Sekine S, Ishiyama K, Oguma J, Daiko H, Kato K. Kadono T, et al. Among authors: yamamoto s. Esophagus. 2023 Jan;20(1):109-115. doi: 10.1007/s10388-022-00951-4. Epub 2022 Sep 1. Esophagus. 2023. PMID: 36050607 Free PMC article.

7

The real-world selection of first-line systemic therapy regimen for metastatic gastroenteropancreatic neuroendocrine neoplasm in Japan.

Yamamoto S, Sakakibara N, Hirano H, Morizane C, Honma Y, Hijioka S, Okusaka T, Higashi T, Kawai A. Yamamoto S, et al. Sci Rep. 2022 Oct 20;12(1):17601. doi: 10.1038/s41598-022-22718-8. Sci Rep. 2022. PMID: 36266484 Free PMC article.

8

Significance of lymphovascular invasion in esophageal squamous cell carcinoma undergoing neoadjuvant chemotherapy followed by esophagectomy.

Oguma J, Ishiyama K, Kurita D, Kanematsu K, Kubo K, Utsunomiya D, Yamamoto S, Honma Y, Kato K, Daiko H. Oguma J, et al. Among authors: yamamoto s. Esophagus. 2023 Apr;20(2):215-224. doi: 10.1007/s10388-022-00973-y. Epub 2022 Dec 24. Esophagus. 2023. PMID: 36565340

9

Progression patterns and site-specific responses in advanced gastric cancer patients treated with nivolumab.

Kadono T, Iwasa S, Nagashima K, Oshima K, Yamamoto S, Hirano H, Okita N, Shoji H, Honma Y, Takashima A, Kato K, Ushijima T, Boku N. Kadono T, et al. Among authors: yamamoto s. Cancer Med. 2023 Apr;12(8):9322-9331. doi: 10.1002/cam4.5689. Epub 2023 Feb 15. Cancer Med. 2023. PMID: 36789624 Free PMC article.

10

Retrospective Analysis of Definitive Chemoradiotherapy With FOLFOX in Patients With Esophageal Cancer Intolerant to Cisplatin.

Yada M, Yamamoto S, Honma Y, Hirano H, Okita N, Shoji H, Iwasa S, Takashima A, Nagahara A, Kato K. Yada M, et al. Among authors: yamamoto s. In Vivo. 2024 Mar-Apr;38(2):761-766. doi: 10.21873/invivo.13499. In Vivo. 2024. PMID: 38418117 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,628 results

Search Page

Filters